Oocyte meiosis is a specialized cell cycle that gives rise to fertilizable haploid gametes and is precisely controlled in various dimensions. We recently found that E3 ubiquitin ligase CRL4 is required for female fertility by regulating DNA hydroxymethylation to maintain oocyte survival and to promote zygotic genome reprogramming. However, not all phenotypes of CRL4-deleted oocytes could be explained by this mechanism. Here we show that CRL4 controls oocyte meiotic maturation by proteasomal degradation of protein phosphatase 2A scaffold subunit, PP2A-A. Oocyte-specific deletion of DDB1 or DCAF1 (also called VPRBP) results in delayed meiotic resumption and failure to complete meiosis I along with PP2A-A accumulation. DCAF1 directly binds to and results in the poly-ubiquitination of PP2A-A. Moreover, combined deletion of Ppp2r1a rescues the meiotic defects caused by DDB1/DCAF1 deficiency. These results provide in vivo evidence that CRL4-directed PP2A-A degradation is physiologically essential for regulating oocyte meiosis and female fertility.
T o produce fertilizable eggs with the appropriate number of chromosome sets, oocyte meiotic progression is precisely regulated 1 . In ovaries of adult female mammals, oocytes are arrested at the diplotene stage of prophase I, which is also called germinal vesicle (GV) stage 2 . A luteinizing hormone surge at oestrus triggers oocyte meiotic resumption in preovulatory follicles, followed by chromosome alignment and spindle organization at prometaphase I (Pro-MI) 3, 4 . Accurate homologous chromosome separation is achieved by cohesion removal after all chromosome pairs are aligned along the spindle equatorial plane 5, 6 . Subsequently, oocytes extrude a first polar body (PB1) and are arrested at metaphase II (MII) to await fertilization. Dysregulated meiotic progression results in aneuploidy and embryonic development abnormality, which contributes to early abortion and female infertility 7 .
Protein phosphatase 2A (PP2A) is a known cell cycle regulator in both somatic cells and oocytes. PP2A consists of a scaffold A subunit, a catalytic C subunit and a regulatory B subunit 8 . Previous studies showed that increased PP2A activity inhibited oocyte GV breakdown (GVBD) by counteracting CDK1 activation 9 . In contrast, genetically deleting Ppp2r1a in oocytes, a gene encoding for the major isoform of the PP2A-A subunit, facilitated GVBD, which suggested that PP2A functioned as an inhibitor of meiotic resumption 10 . In addition, PP2A is required to prevent precocious separation of sister chromatids during oocyte meiosis I 10, 11 . During meiotic division I, sister chromatids are attached to one another by cohesin complexes when homologous chromosomes form tetrads. During the MI-to-AI transition, cohesins on chromosome arms are phosphorylated and then cleaved by separase, while centromeric cohesins are protected by a PP2A-shugoshin complex through dephosphorylation 5, 6, 11, 12 . Although PP2A controls meiotic resumption and ensures accurate chromosome separation, little is known regarding how PP2A protein stability is regulated during cell cycles.
Protein ubiquitin (Ub) E3 ligases, in particular, play key roles during both meiotic and mitotic cell cycle progression by triggering specific proteins degradation. For example, an anaphase promoting complex (APC) initiates the metaphaseanaphase transition by inducing the degradation of cyclin B and securin 13 . Cullin-ring ligase-1 (CRL1) promotes early mitotic inhibitor 1 degradation and facilitates oocyte meiotic resumption and progression to MI 14 . However, it remains unclear whether PP2A is also regulated by the ubiquitination-proteasome pathway as part of the biochemical network that controls the cell cycle.
CRL4 Ub E3 ligase is evolutionally conserved from yeasts to humans. Its core components include cullin 4A or B as a scaffold, damaged DNA-binding protein 1 (DDB1) as a linker, and the ring finger protein ROC1/2 (refs 15,16) . By selectively forming protein complexes with its more than 90 substrate adaptors known as DDB1-CUL4 associated factors (DCAFs), CRL4 regulates a wide range of cellular processes 17, 18 . We previously generated oocyte-specific Ddb1 and Dcaf1 knockout mice and found that CRL4 in complex with one of its substrate adaptors, DCAF1, also known as VPRBP, regulated the hydroxymethylation of genomic DNA to maintain oocyte survival and to promote zygotic genome reprogramming after fertilization 19, 20 . Interestingly, although these knockout mice could ovulate in response to exogenous gonadotropin when they were young, most of their ovulated oocytes had abnormal morphologies, as characterized by the presence of GVs and the absence of PB1s. This suggested that, in addition to maintaining the survival of dormant oocytes, CRL4 DCAF1 was a crucial regulator of meiotic maturation in fully grown oocytes.
In this study we investigate the physiological functions and biochemical mechanisms of CRL4 DCAF1 in regulating mammalian oocyte meiotic maturation. DDB1 or DCAF1 deletion causes delayed meiotic resumption and failure to complete meiosis I in fully grown oocytes. The PP2A-A subunit is accumulated in DDB1-or DCAF1-deleted oocytes, which inhibits cohesin removal and homologous chromosome separation during meiosis I. Biochemistry assays shows that CRL4 DCAF1 binds to PP2A-A and targets it for polyubiquitination and proteasome degradation. Our results demonstrate for the first time that CRL4 DCAF1 Ub E3 ligase is essential for promoting meiotic cell cycle progression by targeting PP2A for degradation in mouse oocytes.
Results CRL4 DCAF1 complexes are essential for oocyte meiosis. To investigate the functions of CRL4 DCAF1 complexes during oocyte meiotic maturation, we selectively deleted Ddb1 or Dcaf1 in oocytes by using previously reported conditional knockout mouse models, Ddb1 fl/fl ;Gdf9-Cre and Dcaf1 fl/fl ;Gdf9-Cre (hereafter referred to as Ddb1 oo À / À and Dcaf1 oo À / À ) 19 . Immunohistochemistry results confirmed that DDB1 and DCAF1 were specifically deleted in oocytes from Ddb1 oo À / À and Dcaf1 oo À / À mice, respectively (Supplementary Fig. 1 ). We then investigated the meiotic maturation of DDB1-and DCAF1-deficient oocytes. In wild-type (WT) females, 95% of the oocytes within preovulatory follicles resumed meiosis and underwent GVBD at 4 h after human chorionic gonadotropin (hCG) administration (Fig. 1a, white arrowheads) . However, in the ovaries of Ddb1 oo À / À and Dcaf1 oo À / À mice, most oocytes within preovulatory follicles had intact GVs (Fig. 1a , black arrowheads) at 4 h post-hCG injection. Only 32.9 and 8.7% of these oocytes underwent GVBD (Fig. 1b) . We superovulated WT, Ddb1 oo À / À and Dcaf1 oo À / À females and collected oocytes at 16 h post-hCG injection. GVBD occurred in 83% of Ddb1 oo À / À oocytes, but none of these oocytes extruded PB1s. More severe defects were observed for Dcaf1 oo À / À oocytes, as only 52.6% of the ovulated oocytes underwent GVBD and none released a PB1 (Fig. 1c,d ). Cultured Ddb1 oo À / À and Dcaf1 oo À / À oocytes also had significantly low GVBD rate and extruded no PB1s in vitro (Fig. 1e-g and Supplementary Fig. 2a ). For the reason that DDB1 protein is more stable than DCAF1, Dcaf1 oo À / À oocytes exhibited stronger phenotypes than Ddb1 oo À / À oocytes 19 .
In addition, Ddb1 oo À / À and Dcaf1 oo À / À oocytes that resumed meiosis had abnormal spindles and misaligned chromosomes ( Supplementary Fig. 2b, arrows) . When superovulated Ddb1 oo À / À females were mated with fertile adult males, 2-cell embryos were not found in their oviducts at 44 h post-hCG injection ( Supplementary Fig 2c,d) .
We then monitored the meiotic maturation of WT and DDB1-deleted oocytes in vitro using live imaging. mRNAs encoding for green fluorescent protein (GFP)-tubulin and RFP-H2B were co-injected into oocytes to demonstrate spindle assembly and chromosome organization. Compared with WT oocytes, GVBD was delayed in DDB1-deleted oocytes. Even after GVBD, these oocytes failed to emit a PB1 and did not complete meiosis I. Although spindles were formed in these oocytes, condensed chromosomes did not align at the equatorial plane ( Supplementary Fig. 3 ).
In DDB1-or DCAF1-deleted oocytes that resumed meiosis within 4 h, lagged chromosomes were frequently observed, as in matured oocytes in vivo ( Fig. 1e and Supplementary Fig. 2a ). Homologous chromosome separation and PB1 emission (PBE) were not observed in these oocytes (Fig. 1e) .
Moreover, when WT oocytes were cultured with MLN4924 (0.1-0.5 mM) 21, 22 , a specific inhibitor of cullin neddylation that inhibits CRL family E3 ligase activity, homologous chromosome alignment and separation and PB1 extrusion were all disrupted ( Supplementary Fig. 4 ). These phenotypes were similar to those observed with Ddb1 oo À / À and Dcaf1 oo À / À oocytes.
Loss of CRL4 inhibits homologous chromosome separation. Chromosome spread analyses showed that the separation of homologous chromosomes was blocked in Ddb1 oo À / À and Dcaf1 oo À / À oocytes (Fig. 2a) . At meiosis I, after homologous chromosome alignment and inactivation of the spindle assembly checkpoint (SAC), APC is activated by forming an APC CDC20 complex and targets securin and cyclin B for degradation, which activates separase and promotes anaphase 23 . Thus, the defects in homologous chromosome separation might have been caused by the inactivation or delayed activation of APC CDC20 . To investigate this, we cultured WT and Ddb1 oo À / À oocytes for the indicated times and lysed them for western blot analysis. In WT oocytes, CDC20 accumulated at 9 h of culture and securin degraded thereafter, which indicated APC CDC20 activation (Fig. 2b) . CDK1-T161 phosphorylation was not significantly affected by DDB1 deletion (Fig. 2b) . Moreover, we microinjected mRNA encoding mCherry-securin into WT and Ddb1 oo À / À oocytes, and monitored the dynamics of mCherry fluorescent levels by live imaging. As shown in Fig. 2c , securin was normally degraded in DDB1-deleted oocytes. Thus, APC CDC20 was activated in DDB1-deleted oocytes, and targeted securin for degradation. The corresponding movies were shown in Supplementary Movie 1 (WT oocytes) and Supplementary 
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Movie 2 (Ddb1 oo À / À oocytes), respectively. Consistent with the activation of APC CDC20 , MAD2, a core component of SAC which concentrates to the centromeres when SAC is active, was not detected in the chromosomes of DDB1-deleted oocytes ( Supplementary Fig. 5 ). These results suggested that APC and separase were activated but failed to separate homologous chromosomes.
During the MI-to-AI transition, cohesin on homologous chromosome arms that holds them together is phosphorylated and cleaved by separase 24 . In WT oocytes, structural maintenance of chromosomes 3 (SMC3), a component of the cohesin complex, was localized to the chromosome axis at early MI, but was removed from chromosome arms and restrictively localized to centromeres at the late MI and MII stages (Fig. 2d) . However, in Ddb1 oo À / À oocytes, SMC3 was retained on the chromosome axis even when the WT oocytes have extruded PB1 (Fig. 2d) . Centromeric cohesins that hold sister chromosomes together are protected by PP2A-shugoshin complexes 25, 26 . In WT oocytes, PP2A was restricted to centromeres during the MI-AI transition (Fig. 2e) . However, increased PP2A-A levels and ectopic PP2A localization on chromosome arms were observed in DDB1-deleted oocytes (Fig. 2e,f) .
In addition to regulating chromosome separation, PP2A is also a repressor of oocyte meiotic resumption 10, 27 . Interestingly, inhibiting PP2A activity with okadaic acid rescued GVBD in both DDB1-and DCAF1-deleted oocytes ( Fig. 3a) , which suggested that PP2A was a possible substrate of CRL4 DCAF1 complexes during meiosis progression.
CRL4 DCAF1 induces proteasome degradation of PP2A-A. We next investigated the biochemical effects of CRL4 DCAF1 activity on PP2A-A degradation. The protein levels of the A subunit (PP2A-A), but not those of the B and C subunits (PP2A-B or PP2A-C), were significantly increased after DDB1/DCAF1 deletion in GV oocytes (Fig. 3b,c and Supplementary Fig. 6a,b) . RNA interference (RNAi)-mediated depletion of CRL4 components (Dcaf1, Ddb1 and Cul4a/b; Fig. 3d and Supplementary Fig. 6c ) increased the protein levels of PP2A-A in HeLa cells. Furthermore, we inhibited de novo protein synthesis using cyclohexamide, and then determined the protein degradation rates of PP2A subunits with or without CRL4 activity. PP2A-A was degraded within 12 h after cyclohexamide inhibition in HeLa cells that were transfected with control siRNA, but was stabilized after depleting CRL4 components ( Fig. 3e and Supplementary Figs 6d,7a) . However, PP2A-B protein levels remained stable throughout 24 h of culture and PP2A-C degradation was not blocked by CRL4 inhibition. Moreover, PP2A-A accumulation was also found in DDB1-deleted hepatocytes collected in vivo (Supplementary Fig. 7b ). These results indicated that PP2A-A, but not PP2A-B or C was degraded in a CRL4 DCAF1 -dependent manner.
CRL4 DCAF1 binds to its substrates via the adaptor protein DCAF1. PP2A-A has two isoforms in mammals, PPP2R1A and PPP2R1B. Co-IP results showed that DCAF1 interacted with both PPP2R1A and PPP2R1B (Fig. 3f) . Because previous studies reported that PPP2R1A played a more important role than did PPP2R1B in oocytes 10 , we conducted the following experiments primarily using PPP2R1A.
DCAF1 interacts with DDB1 through its WD40 domain, which is close to its C terminus, and binds to its substrate with its long N-terminal domain 15 . Thus, we examined PPP2R1A binding with different DCAF1 fragments. As shown in Supplementary Fig. 7c , DCAF1 bound to PPP2R1A through its N-terminal domains. Interestingly, a migration shift of DCAF1-interacting PPP2R1A was detected. This shifted PPP2R1A band was undetectable in DCAF1-N-fragment pull-down samples (Supplementary Fig. 7c) . By western blot analysis using an anti-Ub antibody, we established that this shifted band was ubiquitinated PPP2R1A (Supplementary Fig. 7d) .
Overexpressing CRL4 components, DDB1, DCAF1 or CUL4A, greatly increased the poly-ubiquitination status of PPP2R1A (Fig. 3g) . By comparison, inhibiting CRL4 activity with MLN4924 ( Supplementary Fig. 7e ) or siRNA (Fig. 3h) reduced PPP2R1A poly-ubiquitination levels.
Furthermore, we purified FLAG-tagged PPP2R1A in HEK293 cells and His-tagged DCAF1 N-terminal and C-terminal truncated proteins in Escherichia coli and subjected to in vitro binding assay. PPP2R1A interacted with the N-terminal but not the C-terminal domains of DCAF1 (Fig. 3i) . We also did an in vitro ubiquitination assay to show that PPP2R1A was directly poly-ubiquitinated by CRL4 DCAF1 . FLAG-PPP2R1A or CRL4 DCAF1 complex were purified from HEK293 cells separately. FLAG-PPP2R1A was subjected to ubiquitination assay in the presence of CRL4 DCAF1 or not in the ubiquitination buffer containing recombinant E1, E2, Ub and ATP. As shown in Fig. 3j , PPP2R1A was directly poly-ubiquitinated by CRL4 DCAF1 in a dose-dependent manner.
These results demonstrated that CRL4 DCAF1 bound to PP2A-A and resulted in its proteasome degradation due to its poly-ubiquitination. Inhibiting CRL4 activity resulted in PP2A stabilization in both oocytes and somatic cells.
PP2A-A overexpression mimics DDB1/DCAF1 deletion. The results described above suggested that CRL4 DCAF1 might target PP2A-A for degradation and promote meiotic cell cycle progression in oocytes. Among the three PP2A subunits, PP2A-A protein levels were remarkably reduced during oocyte maturation and fertilization, whereas PP2A-B and -C subunits' expression was stable. Interestingly, this change was accompanied by increased CUL4 neddylation or activity (Fig. 4a,b) .
To investigate if PP2A-A accumulation was the major factor that contributed to the meiotic maturation defects observed in DDB1-and DCAF1-deleted oocytes, we investigated the effects of PPP2R1A overexpression on mouse oocyte maturation. mRNAs encoding for FLAG-PPP2R1A or FLAG-GFP as a control were injected into WT oocytes that were arrested at the GV stage using milrinone. Their protein expression in oocytes was established by western blot analysis (Fig. 4c) . After their release from milrinone, FLAG-PPP2R1A injected oocytes had reduced GVBD and PBE rates (Fig. 4d,e) . Consistent with the observations for DDB1-deleted oocytes (Fig. 2b) , securin degradation was not blocked, but cohesin removal was impaired in FLAG-PPP2R1A overexpressing oocytes (Fig. 4f,g ). For those PPP2R1A overexpressing oocytes that underwent GVBD within 4 h after their release from milrinone, their spindles were disorganized and chromosomes failed to properly align on the equatorial plates (Fig. 4h) . Collectively, PPP2R1A overexpression in oocytes mimicked the phenotypes of DDB1-and DCAF1-deleted oocytes.
PPP2R1A deletion partially rescues DDB1 deletion phenotypes. To confirm that PPP2R1A was a physiological CRL4 substrate, we generated oocyte-specific Ppp2r1a and Ddb1 double knockout mice (Ddb1 fl/fl ;Ppp2r1a fl/fl ;Gdf9-Cre, referred to as Ddb1/Ppp2r1a oo À / À ). Interestingly, the oocytes ovulated by Ddb1 oo À / À mice did not have a PB1 (Fig. 1c) , whereas 75.4% of oocytes ovulated by Ddb1/Ppp2r1a oo À / À females had a PB1 (Fig. 5a) . Immunofluorescent staining for a-tubulin and DNA showed that PB1 was extruded and normally shaped MII spindles formed in Ddb1/Ppp2r1a oo À / À oocytes (Fig. 5b) . The WT control results were similar to those shown in Fig. 1c ,e. However, some chromosomes failed to align at the equatorial plate (Fig. 5b , indicated by arrows), as previously reported for Ppp2r1a oo À / À oocytes 10 .
When cultured in vitro, Ddb1/Ppp2r1a oo À / À oocytes had a remarkably higher GVBD rate (61.8%) than did in Ddb1 oo À / À oocytes (38.7%). However, their GVBD rate was still lower than that of WT oocytes (80.3%; Fig. 5c ). Cultured Ddb1/Ppp2r1a oo À / À oocytes had a PB1 emission rate (68%) comparable to that of WT controls (79%). This was in sharp contrast to that of Ddb1 oo À / À oocytes (1.1%; Fig. 5c-e) . In addition, homologous chromosomes were separated in Ddb1/Ppp2r1a oo À / À oocytes (Fig. 5f) . Moreover, precocious separation of sister chromatids was also observed Target proteins were immunoprecipitated using anti-FLAG agarose beads and subjected to western blotting. Input cell lysates (10%) were immunoblotted with an anti-MYC antibody to show equivalent expression of DCAF1 in all samples. (g) PP2A-A poly-ubiquitination levels were increased after overexpressing CRL4 DCAF1 components. HeLa cells were co-transfected with FLAG-PPP2R1A/B, HA-Ub, and the indicated MYC-tagged protein expression plasmids for 48 h. Target proteins were immunoprecipitated using anti-FLAG agarose beads and subjected to western blotting. (h) RNAi depletion of Dcaf1/Ddb1 resulted in reduced PP2A-A poly-ubiquitination. (i) In vitro binding assay showing that PP2A-A directly interacts with the N terminus of DCAF1. HeLa cells were transfected with FLAG-PPP2R1A expression plasmids for 48 h. Target proteins were immunoprecipitated using anti-FLAG agarose beads. His-tagged N or C terminus of DCAF1 was expressed and purified from E. coli cells. n.s., a non-specific band blotted using an anti-His6 antibody, used as a loading control. (j) PP2A-A is directly poly-ubiquitinated by CRL4 DCAF1 in vitro. HeLa cells were transfected with FLAG-PPP2R1A or FLAG-DCAF1 expression plasmids for 48 h. Target proteins were immunoprecipitated using anti-FLAG agarose beads separately and subjected to ubiquitination assay in the presence of E1, E2 and Ubiquitin. ARTICLE in these oocytes. The chromosomes of Ddb1/Ppp2r1a oo À / À oocytes were a mixture of tetrads (5.1%), dyads (85.3%) and single chromatids (9.6%; Fig. 5f ). This phenotype was previously reported for Ppp2r1a oo À / À oocytes. Collectively, these results indicated that PPP2R1A was a physiological CRL4 DCAF1 substrate in oocytes and that its abnormal accumulation contributed to most of the meiotic maturation-related defects that were observed in CRL4 DCAF1 -deleted oocytes.
Discussion
We previously reported that oocyte-specific deletion of Ddb1 or its substrate adaptor Dcaf1 resulted in a rapid loss of ovarian oocyte reserves and premature ovarian insufficiency at young adulthood 19, 20 . CRL4 DCAF1 activated ten-eleven translocation (TET) DNA hydroxymethylases to regulate DNA methylation and the expression of oocyte-specific genes 19, 20 . However, not all Ddb1 oo À / À mouse phenotypes could be explained by this mechanism. Ddb1 fl/fl ;Gdf9-Cre females were infertile even before their oocytes were exhausted, which was evident at about 3 months after birth. Embryos derived from DDB1-deleted oocytes failed to develop beyond the four-cell stage 19 . This defect was more severe than maternal deletion of TET3 (ref. 28 ). Thus, mechanisms other than TET inactivation must have contributed to the infertile phenotype of Ddb1 oo À / À female mice. In this study we found that CRL4 DCAF1 controlled oocyte meiotic progression as early as 3 weeks after birth, before genomic DNA hypomethylation-caused oocyte gene silencing. These effects were primarily caused by PP2A-A accumulation, as Ppp2r1a knockout in oocytes rescued most of the meiosis defects resulting from DDB1 deletion (summarized in Supplementary  Fig. 8 ). PP2A acted as a guardian of GV arrest and sister chromatid cohesin during meiosis I (refs 10,29) . However, the regulation of PP2A activity during meiotic progression remained elusive. PP2A reportedly interacted with a proteasome Ub system in fission yeast 30 . Mass spectroscopy studies identified an interaction between a PP2A-Aa subunit (PPP2R1A) and CRL4 E3 Ub ligase 18 . On the basis of these clues, we identified a novel mechanism by which PP2A was regulated by CRL4 DCAF1 -mediated proteasome degradation during oocyte meiotic maturation. This is the first study to show a function for CRL4 in vivo by regulating chromosome separation and cell division. Our oocyte-specific gene knockout mouse models and PP2A-A overexpression results indicated that CRL4-mediated PP2A degradation was physiologically important for controlling prophase I arrest and prometaphase progression during meiosis. We also observed that PP2A accumulation in oocytes inhibited SAC activation. During Pro-MI, SAC is activated to inhibit the premature activation of APC/C complexes before successful chromosome alignment. However, in DDB1-deleted oocytes, SAC was not activated when cultured for 8 h and APC complex was activated. This was consistent with the results of previous reports that PP2A directly or indirectly inhibited the phosphorylation of SAC components, thereby causing SAC inactivation 11, 31 . In CRL4 DCAF1 -deleted oocytes, homologous chromosomes were misaligned on the spindles and microtubules failed to pull them apart. Securin was also degraded, which suggested separase activation. Owing to the ectopic expression of PP2A on chromosome arms, separase failed to separate homologous chromosomes during anaphase I.
A recent study investigated the physiological role of microtubule associated serine/threonine kinase-like (MASTL or greatwall kinase), a PP2A suppressor, in mouse oocytes 32 . It was found that MASTL was required for the timely activation of APC during meiosis I exit and was indispensable for meiotic resumption. However, in Mastl oo À / À oocytes, PP2A activity was not dramatically increased as compared with that in WT oocytes at the GV stage and after GVBD. In these oocytes, PP2A activity was only significantly increased after PBE 32 . These results suggested that MASTL primarily inhibited PP2A activity at the relatively later stages of oocyte maturation (metaphase I-II transition). Consistent with these results, delayed PBE was also reported for Mastl oo À / À oocytes. We observed a related phenotype in that homologous chromosome separation and PBE were blocked in Ddb1 oo À / À oocytes or PP2A overexpressing oocytes. These two independent studies suggested that excessive PP2A activation caused these oocyte maturation defects.
A study by Liu et al. and our results suggested that PP2A activity might be controlled by two distinct mechanisms in mouse oocytes. One is a post-translational modification by which MASTL phosphorylates and stabilizes the PP2A inhibitors endosulfine alpha and cAMP-regulated phosphoprotein 19. After phosphorylation, these inhibit PP2A activity to promote anaphase 33 . The other is CRL4-mediated degradation of the PP2A scaffold subunit, which reduces PP2A activity to facilitate non-reversible meiotic progression. These two regulation mechanisms of PP2A activity in conjunction with other meiotic regulators ensure precise meiotic progression in oocytes. This is the first study to report on the functions of CRL4 during metaphase/anaphase of the cell cycle. By forming more than 90 distinct E3 Ub ligases with different substrate adaptors, CRL4 targets different substrates for degradation 16 . Among these, DNA replication licensing factor CDT1 and cyclin-dependent kinase inhibitor 1 (p21) are widely regarded as cell cycle regulators 34 . In somatic cells, ablating CRL4 components causes DNA damage, which arrests the cell cycle before entry into metaphase 35, 36 . These CRL4 functions during interphase restricted investigating its function during metaphase and identifying its new substrates during the cell cycle.
Oogenesis is a specialized cell cycle that involves a long division process (412 h, and B30 min in mitosis). Oocytes enter meiosis and are arrested at the diplotene stage of prophase I early during foetal life. Thus, by using Gdf9-Cre transgenic mice 37 , we could delete DDB1 and DCAF1 in oocytes at the GV stage without causing genomic DNA damage. In this way, we could investigate the specific roles of CRL4 in dividing cells.
PP2A-A protein levels are reduced after GVBD. Thus, we hypothesized that CRL4 activity should be regulated during meiosis. However, it was difficult to determine the CRL4 Ub ligase activity at different stages because the small numbers and sizes of mouse oocytes prevented the purification of endogenous CRL4. The cullin family E3 Ub ligases require a NEDD8 modification to acquire their Ub ligase activity. CRLs activity are controlled by cycles of neddylation, CAND1 binding, and the abundance of adaptor modules 18, 38 . Interestingly, CUL4 neddylation was increased after meiotic resumption. Therefore, on meiotic resumption, CRL4 activity might be upregulated to target PP2A for degradation and facilitate meiotic progression.
Our findings with oocytes have potentially important implications for somatic cells. In HeLa cells, PP2A-A was also ubiquitinated and degraded in a CRL4 DCAF1 -dependent manner. These results indicated that CRL4 might also control the mitotic cell cycle by inhibiting PP2A activity. PP2A is considered to be a tumour suppressor and has important roles during tumorigenesis. PPP2R1A and PPP2R1B are mutated in many cancers, including breast, colon and lung carcinomas and melanoma 39, 40 . Reduced PP2A activity facilitates the ectopic activation of oncogenes, including RalA, b-catenin, BCL2, c-Myc and others [41] [42] [43] . CRL4 components were found to be highly expressed in many types of cancer cells and were required for their proliferation 35 . By identifying PP2A as a novel CRL4 target, our study results provide new insights into the roles of CRL4 during tumorigenesis. Histological analysis and Immunohistochemistry. Mouse ovaries were fixed overnight in 10% PBS-buffered formalin, dehydrated and embedded in paraffin. Ovary samples were serially sectioned (5 mm thick) and stained with hematoxylin and eosin. GVBD rates were determined only for large preovulatory follicles that contained oocytes with clearly visible nuclei at 4 h after hCG injection.
For immunohistochemistry, sections were deparaffinized, rehydrated, and incubated with primary antibodies at room temperature for 1 h, then reacted with biotin-labelled secondary antibodies for 30 min, and finally stained using Vectastain ABC kits and DAB peroxidase substrate kits (Vector Laboratories, Burlingame, CA).
Superovulation and fertilization. For superovulation, 21-23-day-old female mice were injected intraperitoneal with 5 international units (IU) of PMSG (Ningbo Sansheng Pharmaceutical, China) and 44 h later with 5 IU of hCG (Ningbo Sansheng Pharmaceutical, China). After an additional 16 h, oocyte/cumulus masses were surgically removed from oviducts and the numbers of oocytes were counted after digestion with 0.3% hyaluronidase (Sigma-Aldrich). Oocyte morphology was observed and images were acquired with a Nikon SMZ1500 stereoscope.
To obtain early embryos, female mice were mated with 10-12-week-old WT males. Successful mating was confirmed by the presence of vaginal plugs. Zygotes or two-cell embryos were collected from oviducts at the indicated times post-hCG injection.
Confocal microscopy for mouse oocytes. Oocytes were fixed in PBS-buffered 4% paraformaldehyde for 30 min at room temperature, followed by permeabilization with 0.2% Triton X-100. After blocking with 1% bovine serum albumin in PBS, oocytes were incubated with primary antibodies diluted in blocking solution at room temperature for 1 h. After three washes with PBS, oocytes were labelled with secondary antibodies for 45 min, and then counterstained with 5 mg ml À 1 of 4 0 ,6-diamidino-2-phenylindole (DAPI) or propidium iodide (Molecular Probes, Life Technologies, Carlsbad, CA, USA) for 10 min. Oocytes were mounted on glass slides using SlowFade Gold Antifade Reagent (Life Technologies) and examined with a confocal laser scanning microscope (Zeiss LSM 710, Carl Zeiss AG, Germany).
Preparation of chromosome spread sections. Oocytes at different meiosis stages were collected and the zona pellucida was removed using acidic M2 medium (pH 2.0). Then, oocytes were fixed in a CS solution that contained 1% paraformaldehyde, 0.15% Triton X-100 and 3 mM dithiothreitol on glass slides for 30 min. Successful oocyte rupture was monitored under a stereoscope. After fixation, slides were air dried. Immunofluorescent staining of chromosome and centromere proteins was performed as done for oocytes as described above.
Oocyte culture, microinjection and live imaging. Mice at 21-days of age were injected with 5 IU of PMSG and humanely euthanized 44 h later. Oocytes at the GV stage were collected in M2 medium (M7167; Sigma-Aldrich) and cultured in mini-drops of M16 medium (M7292; Sigma-Aldrich) covered with mineral oil (M5310; Sigma-Aldrich) at 37°C in a 5% CO 2 atmosphere. For microinjection, oocytes were collected in M2 medium with 2.5 mM milrinone to inhibit spontaneous GVBD. mRNAs were transcribed in vitro using a SP6 message machine kit (Invitrogen, AM1450). Microinjection was performed using an Eppendorf microinjector.
For live imaging, mRNAs encoding for RFP-H2B, GFP-tubulin and mCherrysecurin were microinjected into WT and DDB1-deleted oocytes and released from milrinone after 2 h. Images of live oocytes were acquired on a DV ELITE High Resolution Invented Living Cell Workstation and imaged at 5 min intervals for 16 h.
Western blot analysis. Protein samples were separated by SDS-PAGE and electrophoretically transferred to PVDF membranes (Millipore). After incubation with primary antibodies followed by an HRP-linked secondary antibody, bands on membranes were disclosed using an Enhanced Chemiluminescence Detection Kit (Amersham). Full-sized uncropped blots of cropped blots used in figures are included in Supplementary Fig. 9 .
Cell culture, plasmid transfection and RNA interference. HeLa cells and HEK293 cells were grown in DMEM (Invitrogen) supplemented with 10% foetal bovine serum (Hyclone) and 1% penicillin-streptomycin solution (Gibco) at 37°C in a humidified 5% CO 2 incubator. The neddylation inhibitor MLN4924 (kind gift of Dr L.J. Jia) was added to cell culture medium at concentrations of 0.1-1 mM. Transient plasmid transfection was done using Lipofectamine 2000 (Invitrogen). RNAi experiments were done using siRNA duplexes (Microsynth, Balgach, Switzerland) to deplete endogenous Dcaf1, Ddb1, or Cul4a/b in HeLa cells. siRNA sequences are 5 0 -UCACAGAGUAUCUUAGAGATT-3 0 for Dcaf1, 5 0 -GGCCAAG AACAUCAGUGUGTT-3 0 for Ddb1, 5 0 -GAAGCUGGUCAUCAAGAACdTdT-3 0 for Cul4a and 5 0 -AAGCCUAAAUUACCAGAAAdTdT-3 0 for Cul4b.
Immunoprecipitation. At 48 h after transfection, cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10% glycerol and 0.5% NP-40; protease and phosphatase inhibitors were added before use). After centrifugation at 12,000g for 10 min, the supernatant was subjected to immunoprecipitation with an anti-FLAG M2 affinity gel (Sigma). After incubation at 4°C for 4 h, beads were washed three times with lysis buffer. SDS sample buffer was added to the beads and the eluates were used for western blot analysis.
Ubiquitination assay. To detect protein ubiquitination status, cells were lysed in denaturing buffer (20 mM Tris, pH 7.4, 50 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate, 0.5% SDS and 1 mM EDTA; protein inhibitors were added before use) followed by sonication. After centrifugation, the supernatant was used for immunoprecipitation.
For an in vitro ubiquitination assay, plasmids encoding for either FLAG-PPP2R1A or FLAG-DCAF1 were transfected into HEK293T cells. Cells were lysed in NP-40 buffer. FLAG-PPP2R1A and CRL4 FLAG-DCAF1 were immunopreciptated with an anti-FLAG M2 affinity gel (Sigma) and eluted with FLAG peptides. Reactions were performed at 37°C for 1 h in the presence of His-Ub, E1, E2 and ATP. Reactants were diluted with denaturing buffer and re-immunopreciptated with an anti-FLAG M2 affinity gel. The immunoprecipitants were subjected to SDS-PAGE and immunoblotted with Ub and His6-tag antibodies.
